Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,405 | 149 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $633.92 | 35 | $0 (2024) |
| Boston Scientific Corporation | $443.63 | 6 | $0 (2024) |
| PFIZER INC. | $310.85 | 17 | $0 (2024) |
| Amgen Inc. | $237.31 | 16 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $223.01 | 3 | $0 (2024) |
| Astellas Pharma US Inc | $216.04 | 11 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $151.76 | 9 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $150.00 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $132.79 | 8 | $0 (2024) |
| Abbott Laboratories | $129.79 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $601.04 | 19 | Aurinia Pharma U.S., Inc. ($118.87) |
| 2023 | $872.99 | 26 | Actelion Pharmaceuticals US, Inc. ($150.00) |
| 2022 | $237.66 | 13 | Abbott Laboratories ($46.07) |
| 2021 | $306.94 | 17 | Janssen Pharmaceuticals, Inc ($138.91) |
| 2020 | $236.94 | 14 | Janssen Pharmaceuticals, Inc ($107.42) |
| 2019 | $547.45 | 23 | Boston Scientific Corporation ($147.10) |
| 2018 | $297.24 | 19 | PFIZER INC. ($75.61) |
| 2017 | $305.01 | 18 | Astellas Pharma US Inc ($104.91) |
All Payment Transactions
149 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $78.00 | General |
| Category: Cardiovascular | ||||||
| 11/13/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $4.29 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/06/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $22.49 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/02/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $21.91 | General |
| Category: Heart Failure and Hypertension | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Cardiology | ||||||
| 09/05/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $118.87 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 08/13/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $29.13 | General |
| Category: Heart Failure and Hypertension | ||||||
| 08/07/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/23/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $115.26 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 04/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/04/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/02/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/20/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/01/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/27/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.01 | General |
| Category: Cardiovascular | ||||||
| 02/14/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/09/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Cardiology | ||||||
| 12/07/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: DIABETES | ||||||
| 12/06/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/05/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/30/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/09/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/12/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 513 | 597 | $71,061 | $32,421 |
| 2022 | 7 | 415 | 491 | $63,954 | $30,946 |
| 2021 | 5 | 263 | 304 | $47,094 | $25,787 |
| 2020 | 4 | 228 | 263 | $49,585 | $17,516 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 103 | 132 | $26,070 | $13,746 | 52.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 119 | 130 | $17,890 | $8,598 | 48.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 51 | 51 | $11,501 | $5,126 | 44.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 20 | 20 | $5,936 | $2,760 | 46.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 174 | 218 | $6,322 | $1,323 | 20.9% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Facility | 2023 | 24 | 24 | $1,824 | $474.95 | 26.0% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Facility | 2023 | 22 | 22 | $1,518 | $393.96 | 26.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 110 | 144 | $27,648 | $15,393 | 55.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 116 | 136 | $18,360 | $9,123 | 49.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 31 | 31 | $6,975 | $2,731 | 39.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 15 | 15 | $4,380 | $2,202 | 50.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 107 | 129 | $3,741 | $746.07 | 19.9% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Facility | 2022 | 19 | 19 | $1,558 | $390.55 | 25.1% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Facility | 2022 | 17 | 17 | $1,292 | $360.83 | 27.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 88 | 111 | $21,312 | $12,672 | 59.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 114 | 132 | $17,820 | $9,785 | 54.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 27 | 27 | $6,075 | $2,854 | 47.0% |
| 93228 | Heart rhythm tracing, computer analysis, and interpretation of patient-triggered events greater than 24-hour ekg up to 30 days | Facility | 2021 | 17 | 17 | $1,394 | $359.89 | 25.8% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 17 | 17 | $493.00 | $115.26 | 23.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 106 | 133 | $17,955 | $7,389 | 41.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 57 | 65 | $12,480 | $5,923 | 47.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 40 | 40 | $9,000 | $3,825 | 42.5% |
| 0298T | Review and interpretation of external ekg recording for more than 48 hours up to 21 days | Facility | 2020 | 25 | 25 | $10,150 | $378.15 | 3.7% |
About Dr. Luis Alvarez, MD
Dr. Luis Alvarez, MD is a Cardiovascular Disease healthcare provider based in Billings, Montana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1417951922.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Luis Alvarez, MD has received a total of $3,405 in payments from pharmaceutical and medical device companies, with $601.04 received in 2024. These payments were reported across 149 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($3,405).
As a Medicare-enrolled provider, Alvarez has provided services to 1,419 Medicare beneficiaries, totaling 1,655 services with total Medicare billing of $106,669. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Clinical Cardiac Electrophysiology
- Location Billings, MT
- Active Since 06/13/2005
- Last Updated 02/28/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1417951922
Products in Payments
- XARELTO (Drug) $633.92
- CAMZYOS (Drug) $223.01
- ELIQUIS (Drug) $212.79
- Corlanor (Drug) $160.62
- UPTRAVI (Drug) $150.00
- WATCHMAN (Device) $147.10
- WATCHMAN Access System (Device) $147.00
- FARXIGA (Drug) $132.79
- LUPKYNIS (Drug) $118.87
- WATCHMAN FLX (Device) $115.26
- LEXISCAN (Drug) $111.13
- Lexiscan (Drug) $104.91
- ENTRESTO (Drug) $98.36
- CHANTIX (Drug) $98.06
- Vascepa (Drug) $87.42
- VERQUVO (Drug) $84.91
- Barostim Neo System (Device) $77.82
- Repatha (Biological) $76.69
- JARDIANCE (Drug) $67.39
- Carnation Ambulatory Monitor (Device) $64.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Billings
Dr. Robert Minor, M.d, M.D
Cardiovascular Disease — Payments: $64,103
Claudia Lama Von Buchwald, Md, MD
Cardiovascular Disease — Payments: $27,275
Joseph Apostol, M.d, M.D
Cardiovascular Disease — Payments: $13,769
Anastasios Saliaris, M.d, M.D
Cardiovascular Disease — Payments: $8,200
Dr. Douglas Waldo, M.d, M.D
Cardiovascular Disease — Payments: $4,912
Dr. Jeffrey Smith, Md, MD
Cardiovascular Disease — Payments: $2,555